Gender differences in mortality in patients with ST-segment elevation myocardial infarction
Grecia I M Raymundo-Martínez1, Diego Araiza-Garaygordobil2, Rodrigo Gopar-Nieto1
1Cardiology Fellow, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico.
Archivos De Cardiologia De Mexico
|November 12, 2020
Summary
Women experiencing ST-segment elevation myocardial infarction (STEMI) face worse outcomes. This study found higher mortality in women with STEMI, though not statistically significant, highlighting a need for increased awareness and faster medical intervention.
Area of Science:
- Cardiology
- Gender Health
- Clinical Research
Context:
- ST-segment elevation myocardial infarction (STEMI) affects both genders but may present with different outcomes.
- Previous research suggests women experience worse outcomes compared to men following STEMI.
Purpose:
- To investigate and determine potential gender differences in mortality among patients diagnosed with STEMI.
- To analyze demographic and clinical data to understand factors influencing STEMI outcomes in men versus women.
Summary:
- A cohort study analyzed 340 STEMI patients (296 males, 44 females) undergoing primary angioplasty or pharmacoinvasive strategies.
- Female patients, though fewer in number, exhibited higher risk scores, longer ischemic times, and longer first medical contact times.
- While the observed mortality rate was higher in women (9.1%) compared to men, this difference did not reach statistical significance, likely due to limited female representation.
Impact:
- The findings underscore a potential, though not statistically significant, increased mortality risk for women with STEMI.
- Highlights the critical need for greater public awareness regarding STEMI symptoms in women.
- Suggests that delays in seeking medical attention, indicated by longer first medical contact and ischemic times in women, may contribute to poorer outcomes.
More Related Videos
10:44Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
Published on: December 9, 2013
12.2K
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.6K
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
418
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
418
01:30Acute Coronary Syndrome III: Diagnostic Studies
111
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
111
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
227
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
227
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
605
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
605
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
104
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
104
01:20Comparing the Survival Analysis of Two or More Groups
423
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
423